https://www.selleckchem.com/pr....oducts/pmsf-phenylme
5months and 14.0months, respectively ( = .023). Multivariate analysis showed that postoperative cfDNA, tumour number and microvascular invasion ( .05 were independent risk factors for recurrence in operable HCC. Postoperative cfDNA is still a promising marker to predict prognosis in postoperative HCC patients although prospective and large multicenter clinical study is needed to further validate the relationship between cfDNA and HCC recurrence. Postoperative cfDNA is still a promising marker to predi
Beğen
Yorum Yap
Paylaş
